Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML)

M Michallet1, T Bénet, M Sobh

  • 1Hematology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, 5 Place d'Arsonval, 69437, Lyon Cedex 03, France. mauricette.michallet@chu-lyon.fr

Insights

Invasive aspergillosis (IA) significantly increases mortality risk in acute myeloid leukemia (AML) patients undergoing induction chemotherapy. This fungal infection drastically reduces survival rates, regardless of treatment response.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Oncology

Background:

  • Invasive aspergillosis (IA) poses a significant threat during induction chemotherapy for acute myeloid leukemia (AML).
  • IA can complicate treatment strategies and negatively impact patient prognosis.

Purpose of the Study:

  • To investigate how IA development affects AML therapeutic strategies.
  • To evaluate the short- and long-term survival impact of IA in AML patients.

Main Methods:

  • Retrospective analysis of newly diagnosed AML patients (2004-2007).
  • Cox proportional hazards model used to assess the impact of IA diagnosis and treatment response on survival.
  • 262 patients analyzed; 58 cases of IA observed.

Main Results:

  • Two-year survival was 54% for AML remission patients versus 5% for chemotherapy failure patients (p < 0.001).
  • Two-year survival was 14% for patients with IA versus 32% for patients without IA (p = 0.01).
  • Multivariate analysis revealed IA significantly increased death risk in both remission (HR=1.66) and failure (HR=6.43) groups.

Conclusions:

  • IA is associated with a substantially increased risk of death in AML patients.
  • The negative survival impact of IA persists irrespective of remission or chemotherapy failure status.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...